Neurological deficit scores, blood clotting index, liver and renal function were examined before and after treatment in both groups.
两组治疗前后均进行神经功能缺损程度评分，凝血指标和肝肾功能检查。
There were significant difference between group A and group B in the prognosis neurological deficit scores(NDS) and activity daily living(ADL) (P<0.05).
两组预后神经功能缺损评分和日常生活质量评分比较有显著性差异（P<0.05）。
The efficacy was assessed using the neurological functional deficit scores, and the safety was monitored by comparison of the hepatic and renal function before and after the infusion.
评价治疗前后神经功能缺失评分的变化及疗效，监测用药前后肝、肾功能的变化。
Brain tissue was taken out to undergo TTC and HE staining and neurological deficit sign scores were performed.
取脑组织作ttc染色和HE染色，并进行神经功能缺陷体征评分。
Brain tissue was taken out to undergo TTC and HE staining and neurological deficit sign scores were performed.
取脑组织作ttc染色和HE染色，并进行神经功能缺陷体征评分。
应用推荐